Cytochrome P450 3As gene expression and testosterone 6β-hydroxylase activity in human fetal membranes and placenta at full term

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 2, 2010, Pages 249-254

  Maezawa, Kayoko ^a,d   Matsunaga, Tamihide ^a,e   Takezawa, Takashi ^a   Kanai, Makoto ^b   Ohira, Satoshi ^c   Ohmori, Shigeru ^a  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KEIO UNIVERSITY   (Japan)

^e NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Amnion; Chorion; Cytochrome P450 3A; Decidua; Fetal membrane; Testosterone 6 hydroxylation

Indexed keywords

CARBAMAZEPINE; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; DEXAMETHASONE; HYDROCORTISONE; LEVOTHYROXINE SODIUM; MESSENGER RNA; METHYLPREDNISOLONE; RITODRINE; ZONISAMIDE;

ADRENAL INSUFFICIENCY; AMNION; ARTICLE; CESAREAN SECTION; CHORION; DECIDUA; DELIVERY; EPILEPSY; FEMALE; FETUS; FETUS MEMBRANE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOGENATE; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; NEPHROSIS; NUCLEOTIDE SEQUENCE; PLACENTA; PREGNANT WOMAN; PREMATURE LABOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TERM BIRTH; WESTERN BLOTTING;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP3A; ENZYME ACTIVATION; EXTRAEMBRYONIC MEMBRANES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFANT, NEWBORN; ISOENZYMES; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; STEROID HYDROXYLASES; TERM BIRTH;

EID: 76049130574     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.249     Document Type: Article

References (44)

1. Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W., Pharmacogenetics, 6, 1-42 (1996).
2. Shimada T., Yamazaki H., J. Pharmacol. Exp. Ther., 270, 414-423 (1994).
3. Wienkers L. C., Health T. G., Nat. Rev. Drug Discov., 4, 825-833 (2005).
4. Schuetz J. D., Beach D. L., Guzelian P. S., Pharmacogenetics, 4, 11-20 (1994).
5. Kuehl P., Zhang J., Lin Y., Lamba J., Assem M., Schuetz J., Watkins P. B., Daly A., Wrighton S. A., Hall S. D., Maurel P., Relling M., Brimer C., Yasuda K., Venkataramanan R., Strom S., Thummel K., Boguski M. S., Schuetz E., Nat. Genet., 27, 383-291 (2001).
6. Stevens J. C., Hines R. N., Gu C., Koukouritaki S. B., Manro J. R., Tandler P. J., Zaya M. J., J. Pharmacol. Exp. Ther., 307, 573-582 (2003).
7. Pasanen M., Adv. Drug Deliv. Rev., 38, 81-97 (1999).
8. Syme M. R., Paxton J. W., Keelan J. A., Clin. Pharmacokinet., 43, 487-514 (2004).
9. Collier A. C., Tingle M. D., Paxton J. W., Mitchell M. D., Keelan J. A., Hum. Reprod., 17, 2564-2572 (2002).
10. Hakkola J., Raunio H., Purkunen R., Pelkonen O., Saarikoski S., Cresteil T., Pasanen M., Biochem. Pharmacol., 52, 379-383 (1996).
11. Hakkola J., Pasanen M., Pelkonen O., Hukkanen J., Evisalmi S., Anttila S., Rane A., Mäntylä M., Purkunen R., Saarikoski S., Tooming M., Raunio H., Carcinogenesis, 18, 391-397 (1997).
12. Myllynen P., Pasanen M., Vähäkangas K., Expert Opin. Drug Metab. Toxicol., 3, 331-336 (2007).
13. Wright M. R., Rurak D. W., van der Weyde M. P., Taylor S. M., Axelson J. E., J. Pharmacol. Exp. Ther., 258, 897-902 (1991).
14. Aye I. L., Paxton J. W., Evseenko D. A., Keelan J. A., Placenta, 28, 868-877 (2007).
15. Yeboah D., Kalabis G. M., Sun M., Ou R. C., Matthews S. G., Gibb W., Reprod. Fertil. Dev., 20, 328-334 (2008).
16. Geick A., Eichelbaum M., Burk O., J. Biol. Chem., 276, 14581-14587 (2001).
17. Farm F., Pohixuan T., Omiecinski C., Toxicol. Appl. Pharmacol., 124, 1-9 (1994).
18. Mäenpää J., Rane A., Raunio H., Honkakoski P., Pelkonen O., Biochem. Pharmacol., 45, 899-907 (1993).
19. Rasheed A., Hines R., McCarver-May D., Toxicol. Appl. Pharmacol., 144, 396-400 (1997).
20. Kitada M., Kamataki T., Itahashi K., Rikihisa T., Kato R., Kanakubo Y., Biochem. Biophys. Res. Commun., 131, 1154-1159 (1985).
21. Laemmli U. K., Nature (London), 227, 680-685 (1970).
22. Matsunaga T., Tanaka H., Komura A., Watanabe K., Yamamoto I., Yoshimura H., Arch. Biochem. Biophys., 348, 56-64 (1997).
23. Towbin H., Staehelin T., Gordon J., Proc. Natl. Acad. Sci. U.S.A., 76, 4350-4354 (1979).
24. Ring J. A., Ghabrial H., Ching M. S., Smallwood R. A., Morgan D. J., Pharmacol. Ther., 84, 429-445 (1999).
25. Rurak D. W., Wright M. R., Axelson J. E., J. Dev. Physiol., 15, 33-44 (1991).
26. Meunier V., Bourrie M., Julian B., Marti E., Guillou F., Berger Y., Fabre G., Xenobiotica, 30, 589-607 (2000).
27. Luo G., Cunningham M., Kim S., Burn T., Lin J., Sinz M., Hamilton G., Rizzo C., Jolley S., Gilbert D., Downey A., Mudra D., Graham R.,Carroll K., Xie J., Madan A., Parkinson A., Christ D., Selling B., LeCluyse E., Gan L. S., Drug Metab. Dispos., 30, 795-804 (2002).
28. Madan A., Graham R. A., Carroll K. M., Mudra D. R., Burton L. A., Krueger L. A., Downey A. D., Czerwinski M., Forster J., Ribadeneira M. D., Gan L. S., LeCluyse E. L., Zech K., Robertson P. Jr., Koch P., Antonian L., Wagner G., Yu L., Parkinson A., Drug Metab. Dispos., 31, 421-431 (2003).
29. Pelkonen O., Jouppila P., Kirki N. T., Arch. Int. Pharmacodyn. Ther., 202, 288-297 (1973).
30. Pienimaki P., Lampela E., Hakkola J., Arvela P., Raunio H., Vihakangas K., Epilepsia, 38, 309-316 (1997).
31. Paakki P., Kirkinen P., Helin H., Pelkonen O., Raunio H., Pasanen M., Placenta, 21, 241-246 (2000).
32. Urquhart B. L., Tirona R. G., Kim R. B., J. Clin. Pharmacol., 47, 566-578 (2007).
33. Martinez-Jimenez C. P., Jover R., Donato M. T., Castell J. V., Gomez-Lechon M. J., Curr. Drug Metab., 8, 185-194 (2007).
34. Burk O., Koch I., Raucy J., Hustert E., Eichelbaum M., Brockmöller J., Zanger U. M., Wojnowski L., J. Biol. Chem., 279, 38379-38385 (2004).
35. Bertilsson G., Berkenstam A., Blomquist P., Biochem. Biophys. Res. Commun., 280, 139-144 (2001).
36. Kamiyama Y., Matsubara T., Yoshinari K., Nagata K., Kamimura H., Yamazoe Y., Drug Metab. Pharmacokinet., 22, 287-298 (2007).
37. Kojima K., Nagata K., Matsubara T., Yamazoe Y., Drug Metab. Pharmacokinet., 22, 276-286 (2007).
38. Pavek P., Dvorak Z., Curr. Drug Metab., 9, 129-143 (2008).
39. Nishimura M., Yaguti H., Yoshitsugu H., Naito S., Satoh T., Yakugaku Zasshi, 123, 369-375 (2003).
40. Pavek P., Cerveny L., Svecova L., Brysch M., Libra A., Vrzal R., Nachtigal P., Staud F., Ulrichova J., Fendrich Z., Dvorak Z., Placenta, 28, 1004-1011 (2007).
41. Ohmori S., Nakasa H., Asanome K., Kurose Y., Ishii I., Hosokawa M., Kitada M., Biochim. Biophys. Acta, 1380, 297-304 (1998).
42. Aoyama T., Yamano S., Waxman D. J., Lapenson D. P., Meyer U. A., Fisher R., Tyndale R., Inaba T., Werner K., Gelboin H. V., Gonzalez F. J., J. Biol. Chem., 264, 10388-10395 (1989).
43. Waxman D. J., Lapenson D. P., Aoyama T., Gelboin H. V., Gonzalez F. J., Korzekwa K., Arch. Biochem. Biophys., 290, 160-166 (1991).
44. Rendic S., Drug Metab. Rev., 34, 83-448 (2002).